“As new novel compounds are approved from the FDA and DEA, sufferers who may have not located relief from conventional medicines will now have another,” states Nicholson.The annual NSDUH study provides estimates of compound use and mental health indicators from a randomly-selected sample representative of the overall US civilian non-institution